Huatai (06886): Reissue of the "Securities and Futures Business License"
Huatai Securities (06886) announced that on June 26, 2026, the company's 2025 annual general meeting approved the proposal on the adjustment of the company's business scope, agreeing to transfer the underwriting business of non-financial corporate debt financing instruments and financial bonds (excluding policy financial bonds) to its investment banking subsidiary, Huatai United Securities Co., Ltd., for centralized implementation. It also agreed to authorize the company's management team to handle matters related to the change in the scope of the company's business operations. The company has received the "Approval from the Jiangsu Securities Regulatory Bureau on Huatai Securities Co., Ltd.'s Reduction of Business" (Jiangsu Securities Regulatory Permission [2026] No. 2), and the Jiangsu Securities Regulatory Bureau has approved the company's reduction of the aforementioned business.
Huatai (06886) announced that on June 26, 2026, the company's annual shareholders' meeting for 2025 reviewed and approved the proposal regarding the change in the company's business scope. It agreed to transfer the underwriting business of debt financing instruments for non-financial enterprises and financial bonds (excluding policy financial bonds) to its investment banking subsidiary, Huatai United Securities Co., Ltd., for overall implementation, and authorized the company's management to handle matters related to the change in the company's business scope. The company has received the "Approval from Jiangsu Securities Regulatory Bureau for Huatai Co., Ltd. to Reduce Business" (Jiangsu Securities Regulatory License [2026] No. 2), approving the company to reduce the aforementioned business.
Recently, the company received a renewed "Securities and Futures Business License" from the China Securities Regulatory Commission, with the changed scope of securities and futures business as follows: securities brokerage; securities investment consulting; securities underwriting (limited to underwriting government bonds and policy financial bonds); proprietary trading of securities; margin financing and securities lending; sales of public securities investment funds; agency sales of financial products; custody of securities investment funds; market making for stock options; market making trading of listed securities.
Related Articles
IRC (01029) issued a profit warning, expecting that the profit attributable to shareholders for the first half of the year will not exceed 1 million US dollars, turning from a loss to a profit year-on-year.

MICROTECH MED-B (02235) released its interim results, with a net profit attributable to the parent company of 40.2732 million yuan, turning a profit compared to the same period last year.

SEA HOLDINGS (00251) reported its interim results, with a loss attributable to shareholders of approximately HKD 137 million, a year-on-year decrease of 14.1%.
IRC (01029) issued a profit warning, expecting that the profit attributable to shareholders for the first half of the year will not exceed 1 million US dollars, turning from a loss to a profit year-on-year.
MICROTECH MED-B (02235) released its interim results, with a net profit attributable to the parent company of 40.2732 million yuan, turning a profit compared to the same period last year.

SEA HOLDINGS (00251) reported its interim results, with a loss attributable to shareholders of approximately HKD 137 million, a year-on-year decrease of 14.1%.

RECOMMEND





